Peñalver F J, Romero R, Forés R, Cabrera R, Díez-Martin J L, Regidor C, Fernández M N
Department of Hematology, Clínica Puerta de Hierro, Universidad Autónoma de Madrid, Spain.
Bone Marrow Transplant. 1998 Oct;22(8):817-8. doi: 10.1038/sj.bmt.1701432.
A 24-year-old male developed cytogenetic relapse of chronic myeloid leukemia (CML) four years after allogeneic BMT. After a year of treatment with IFN-alpha, he achieved a partial cytogenetic response. Treatment with donor leukocyte infusions (DLI) was given (total dose 1 x 10(8) T lymphocytes/kg). Two months later, he developed acute GVHD (skin and liver), that improved with CsA and methylprednisolone and resulted in cytogenetic remission with complete donor chimerism. One month later he developed rhinocerebral mucormycosis and was successfully treated with surgical debridement and liposomal amphotericin B (total dose 12 g). This is the first case of mucormycosis described after DLI.
一名24岁男性在异基因骨髓移植后四年出现慢性髓性白血病(CML)细胞遗传学复发。在接受α干扰素治疗一年后,他达到了部分细胞遗传学缓解。给予供体白细胞输注(DLI)治疗(总剂量为1×10⁸个T淋巴细胞/kg)。两个月后,他发生了急性移植物抗宿主病(皮肤和肝脏),经环孢素A和甲泼尼龙治疗后病情改善,并实现了细胞遗传学缓解及完全供体嵌合。一个月后,他发生了鼻脑毛霉菌病,通过手术清创和脂质体两性霉素B(总剂量为12g)成功治疗。这是第一例在DLI后描述的毛霉菌病病例。